ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,336.39
      1.21%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      12/21/20185:19PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
      12/21/20185:12PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
      12/21/20185:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      12/19/20181:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/30/20185:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/30/20185:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/30/20185:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/10/20188:15AMGlobeNewswire Inc.Esperion Announces Late-Breaking Oral Presentation of Final Study 3 Results (1002-046) of Bempedoic Acid at the American Hear...NASDAQ:ESPREsperion Therapeutics Inc
      11/08/20188:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
      11/02/20185:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20184:24PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20184:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/01/20184:05PMGlobeNewswire Inc.Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2018 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      10/30/20184:44PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
      10/30/20184:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      10/29/20187:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      10/28/20185:10PMGlobeNewswire Inc.Esperion Announces Completion of Phase 3 LDL-C Lowering Development Program of Bempedoic Acid and Positive Cumulative Results...NASDAQ:ESPREsperion Therapeutics Inc
      10/28/20185:00PMGlobeNewswire Inc.Esperion Announces Positive Top-Line Results from Final Pivotal Phase 3 Study of Bempedoic AcidNASDAQ:ESPREsperion Therapeutics Inc
      10/18/20185:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      10/18/20185:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/29/20184:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      08/27/20187:17AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      08/27/20187:00AMGlobeNewswire Inc.Esperion Announces Positive Top-Line Results from Pivotal Phase 3 Bempedoic Acid / Ezetimibe Combination Pill StudyNASDAQ:ESPREsperion Therapeutics Inc
      08/25/20185:45AMGlobeNewswire Inc.Esperion Announces Late-Breaking Oral Presentation of Final Results of Phase 3 Long-Term Safety Study of Bempedoic Acid at th...NASDAQ:ESPREsperion Therapeutics Inc
      08/22/20187:19AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      08/10/20184:30PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
      08/06/20183:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20184:35PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20187:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      08/02/20187:00AMGlobeNewswire Inc.Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2018 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR